S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:ARTL

Artelo Biosciences Earnings Date, Estimates, & History

$0.71
-0.01 (-1.39%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.68
$0.73
50-Day Range
$0.71
$1.17
52-Week Range
$0.54
$3.67
Volume
1.22 million shs
Average Volume
4.99 million shs
Market Capitalization
$17.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.1
Skip Charts & View Estimated and Actual Earnings Data

Artelo Biosciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Artelo Biosciences Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Artelo Biosciences (NASDAQ:ARTL) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.44 EPS
Next Year EPS Consensus Estimate: $-0.34 EPS

ARTL Earnings Information

Artelo Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 1st, 2021 based off prior year's report dates.

Artelo Biosciences (NASDAQ:ARTL) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
12/1/2021
(Estimated)
        
7/11/20215/31/2021($0.07)($0.10)($0.03)($0.10)
4/12/20212/28/2021($0.12)($0.03)+$0.09($0.11)
1/13/202111/30/2020($0.10)($0.14)($0.04)($0.14)
11/9/2020Q4($0.36)($0.20)+$0.16($0.20)  
7/13/2020Q3($0.40)($0.27)+$0.13($0.27)
4/14/2020Q2($0.53)($0.40)+$0.13($0.40)
1/14/2020Q1 2020($0.38)($0.38)($0.37)
11/25/2019Q4 2019($0.42)($0.42)($0.42)
7/15/2019Q3 2019($0.65)($0.65)($0.90)
4/15/2019Q2 2019($0.07)($0.07)($0.09)
1/14/2019Q1 2019($0.04)($0.04)($0.04)
11/29/2018Q4 2018($0.09)($0.09)($0.09)
7/13/2018Q3 2018($0.05)($0.05)($0.05)
4/16/2018Q2 2018($0.05)($0.05)($0.05)
1/16/2018Q1 2018($0.02)($0.02)($0.02)
(Earnings results data provided by Zacks Investment Research)












Artelo Biosciences (NASDAQ:ARTL) Earnings Frequently Asked Questions

When is Artelo Biosciences's earnings date?

Artelo Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 1st, 2021 based off last year's report dates. Learn more on ARTL's earnings history

How much profit does Artelo Biosciences generate each year?

Artelo Biosciences (NASDAQ:ARTL) has a recorded net income of -$4.66 million. ARTL has generated -$0.55 earnings per share over the last four quarters.

What is Artelo Biosciences's EPS forecast for next year?

Artelo Biosciences's earnings are expected to grow from ($0.44) per share to ($0.34) per share in the next year.

This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.